Please login to the form below

Not currently logged in

UCB’s antiepileptic drug gains new US indication


FDA approves Briviact as a monotherapy to treat POS

FDA approves Medtronic's tablet-controlled pain device

Medtronic SamsungThe Intellis system can be programmed via a Samsung's Galaxy S2

With US approval, GSK now needs rapid uptake for COPD triple

GSK GlaxoSmithKline houseAims to quickly launch the predicted blockbuster to revive its R&D portfolio

NICE says OK to Opdivo for lung cancer via CDF

Bristol-Myers Squibb (BMS) buildingComes after BMS drops the price of its PD-1 inhibitor

MSD's Keytruda wins new bladder cancer indication in Europe

merck-keytruda-pembrolizumab-melanomaWill treat locally advanced or mUC patients

AbbVie and Roche plan Venclexta combo filings in leukaemia

MURANO trial shows the duo’s treatment extends PFS

CHMP backs maintenance therapy for Tesaro's Zejula

Swiss biotech's PARP inhibitor recommended for approval in ovarian cancer

Bayer bags speedy US approval for lymphoma drug Aliqopa

Bayer symbolFDA decision sets the pharma firm up for a showdown with Gilead's Zydelig

GSK's Shingrix sails through FDA advisory committee

GSK - logo on buildingShingles vaccine data proved safe and effective, says the panel

SMC gives green light for Amgen’s Kyprolis

The committee also gives verdict on three other products

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
How Transparent Is Transparency?
The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little...
Geraldine Murphy
LEO: Patients benefit from transparency
Paving the way for openness in pharma...